Insider Selling: Astera Labs (NASDAQ:ALAB) CEO Sells 2,967 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) CEO Jitendra Mohan sold 2,967 shares of Astera Labs stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $174.60, for a total value of $518,038.20. Following the sale, the chief executive officer directly owned 4,405,015 shares of the company’s stock, valued at $769,115,619. This trade represents a 0.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

  • On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The stock was sold at an average price of $149.68, for a total value of $18,522,900.00.
  • On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00.
  • On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The shares were sold at an average price of $123.81, for a total value of $11,758,359.51.

Astera Labs Trading Down 0.7%

Shares of Astera Labs stock traded down $1.28 on Thursday, hitting $170.81. The stock had a trading volume of 4,518,530 shares, compared to its average volume of 4,828,785. Astera Labs, Inc. has a 52-week low of $52.56 and a 52-week high of $262.90. The stock has a market cap of $29.25 billion, a price-to-earnings ratio of 159.34, a P/E/G ratio of 3.39 and a beta of 1.78. The company’s 50 day moving average price is $129.19 and its 200 day moving average price is $154.42.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period in the previous year, the business earned $0.37 EPS. The business’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analysts Set New Price Targets

ALAB has been the subject of several research reports. Citigroup began coverage on Astera Labs in a report on Thursday, April 2nd. They issued a “buy” rating and a $200.00 target price for the company. Loop Capital began coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Finally, Royal Bank Of Canada began coverage on Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $199.44.

Check Out Our Latest Report on Astera Labs

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Nordea Investment Management AB purchased a new stake in shares of Astera Labs during the 4th quarter worth approximately $2,028,000. Geneva Partners LLC purchased a new stake in shares of Astera Labs during the 3rd quarter worth approximately $1,876,000. Numerai GP LLC boosted its stake in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares in the last quarter. Handelsbanken Fonder AB boosted its stake in shares of Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after acquiring an additional 93,800 shares in the last quarter. Finally, Corient Private Wealth LLC purchased a new stake in shares of Astera Labs during the 2nd quarter worth approximately $543,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.